REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $45,000 | -65.6% | 52,198 | +0.3% | 0.00% | – |
Q1 2022 | $131,000 | +3.1% | 52,031 | +6.1% | 0.00% | – |
Q4 2021 | $127,000 | -41.2% | 49,040 | +3.9% | 0.00% | – |
Q3 2021 | $216,000 | -71.4% | 47,213 | -56.9% | 0.00% | – |
Q2 2021 | $754,000 | +9.3% | 109,594 | +16.2% | 0.00% | – |
Q1 2021 | $690,000 | -26.5% | 94,284 | -15.2% | 0.00% | – |
Q4 2020 | $939,000 | -9.6% | 111,191 | +9.4% | 0.00% | – |
Q3 2020 | $1,039,000 | +1198.8% | 101,643 | +749.4% | 0.00% | – |
Q2 2020 | $80,000 | -81.2% | 11,967 | -87.3% | 0.00% | – |
Q1 2020 | $426,000 | -12.0% | 94,084 | +18.1% | 0.00% | – |
Q4 2019 | $484,000 | – | 79,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 300 | $2,175 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |